Copy

Autoimmunity
December 2019
ESL Biosciences, in partnership with Euroimmun AG, offer the most comprehensive range of diagnostic products and services for the determination of autoantibodies

[NEW] EUROIMMUN Anti-sCD163 ELISA (Urine)
Non-Invasive Diagnosis of Acute Glomerulonephritis in AAV or Active Lupus Nephritis

Soluble CD163 is a macrophage activation marker. The sCD163 level in urine correlates directly with the kidney disease activity, reflecting the accumulation of CD163+ macrophages in the glomeruli in response to pro-inflammatory stimuli. 
 
A study led by Professor Mark Little showed that:
  • sCD163 levels in urine have increased significantly in up to 87% of patients with active ANCA-associated vasculitis (AAV) with renal involvement
  • Only slight increase in sCD163 was detected in AAV patients in remission, patients with acute kidney failure or sepsis, and patients with AAV without kidney involvement
EUROIMMUN sCD163 ELISA (Urine)
  • The only commercially available CE-marked assay for detection or urinary sCD163
  • Monoclonal anti-sCD163 antibodies are used for coating
  • Reliable, quantitative detection of sCD163 in urine
  • Detection and monitoring of acute renal ANCA-associated vasculitis, GBM diseases and lupus nephritis
  • A non-invasive diagnostic and monitoring tool that may reduce the number of kidney biopsies
Test Datasheet 
Reproducibility , Sensitivity and Specificity


 
There was great interest among KOL and clinicians on the use sCD163 as a new monitoring marker for renal AAV at the International Vasculitis and ANCA workshop 2019.  Four presentations on CD163 were given at the meeting.
 
Speak to One of Our Representatives to Learn More About the New EUROIMMUN sCD163 ELISA 
NZ
NZ
Australia
Australia
Website
Website
Twitter
Twitter
Facebook
Facebook
LinkedIn
LinkedIn
Google+
Google+
Copyright © 2019 ESL Biosciences (New Zealand) Limited. All rights reserved.
unsubscribe from this list  |  update subscription preferences